Company / R&D per Share
Zenas BioPharma, Inc. R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.02
FY2025
5-year range
$4.02 / $39.21
FY2023-FY2025
Trend
-89.4%
vs FY2024
Sector context
#52 of 208
Health Care
What the data says
Zenas BioPharma, Inc.'s r&d per share of $4.02 is higher than 75% of companies in the Health Care sector (FY2025). Declined from $39.21 to $4.02 over the past 2 years.
Based on SEC 10-K filings.
4.02 in FY2025. Top quartile in the Health Care sector.
Declined from $39.21 to $4.02 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 208This company $4.02 Sector average $28.82
▼
-86.0% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 89.4% year-over-year.
- Ranks #52 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.02 | -89.4% |
| FY2024 | $38.07 | -2.9% |
| FY2023 | $39.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026